Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 158

1.

Having caregiving responsibilities affects management of fragility fractures and bone health.

Sale JEM, Frankel L, Paiva J, Saini J, Hui S, McKinlay J, Sharma S, Cheng L, Bogoch E.

Osteoporos Int. 2020 Mar 28. doi: 10.1007/s00198-020-05385-1. [Epub ahead of print]

PMID:
32222788
2.

Predictors of Treatment Failure for Hip and Knee Prosthetic Joint Infections in the Setting of 1- and 2-Stage Exchange Arthroplasty: A Multicenter Retrospective Cohort.

Kandel CE, Jenkinson R, Daneman N, Backstein D, Hansen BE, Muller MP, Katz KC, Widdifield J, Bogoch E, Ward S, Sajja A, Jeldes FG, McGeer A.

Open Forum Infect Dis. 2019 Oct 21;6(11):ofz452. doi: 10.1093/ofid/ofz452. eCollection 2019 Nov.

3.

Multiple simultaneous fractures are associated with higher all-cause mortality: results from a province-wide fracture liaison service.

Sujic R, Luo J, Beaton DE, Bogoch ER, Sale JEM, Jaglal S, Jain R, Mamdani M; Ontario Osteoporosis Strategy Fracture Screening and Prevention Program Evaluation Team.

Osteoporos Int. 2020 Feb;31(2):291-296. doi: 10.1007/s00198-019-05207-z. Epub 2019 Nov 13.

PMID:
31720710
4.

Five-year refracture rates of a province-wide fracture liaison service.

Sujic R, Beaton DE, Mamdani M, Cadarette SM, Luo J, Jaglal S, Sale JEM, Jain R, Bogoch E; Ontario Osteoporosis Strategy Fracture Screening and Prevention Program Evaluation Team.

Osteoporos Int. 2019 Aug;30(8):1671-1677. doi: 10.1007/s00198-019-05017-3. Epub 2019 May 31.

PMID:
31152183
5.

A rationale for universal tranexamic acid in major joint arthroplasty: overall efficacy and impact of risk factors for transfusion.

Pavenski K, Ward SE, Hare GMT, Freedman J, Pulendrarajah R, Pirani RA, Sheppard N, Vance C, White A, Lo N, Waddell JP, Ho A, Schemitsch EH, Kataoka M, Bogoch ER, Saini K, David Mazer C, Baker JE.

Transfusion. 2019 Jan;59(1):207-216. doi: 10.1111/trf.14995. Epub 2018 Nov 1.

PMID:
30383292
6.

Treatment recommendations based on fracture risk status are not consistently provided in osteoporosis guidelines.

Sale JEM, Gray M, Mancuso D, Inrig T, Boire G, Beaulieu MC, Funnell L, Bogoch E.

Rheumatol Int. 2018 Dec;38(12):2193-2208. doi: 10.1007/s00296-018-4181-3. Epub 2018 Oct 26. Review.

PMID:
30367203
7.

Identifying and Addressing Barriers to Osteoporosis Treatment Associated with Improved Outcomes: An Observational Cohort Study.

Rotondi NK, Beaton DE, Sujic R, Sale JEM, Ansari H, Elliot-Gibson V, Bogoch ER, Cullen J, Jain R, Slater M; Ontario Osteoporosis Strategy Fracture Clinic Screening Program Evaluation Team.

J Rheumatol. 2018 Nov;45(11):1594-1601. doi: 10.3899/jrheum.170915. Epub 2018 Sep 1.

PMID:
30173147
8.

A Missed Opportunity in Bone Health: Vitamin D and Calcium Use in Elderly Femoral Neck Fracture Patients Following Arthroplasty.

Sprague S, Madden K, Slobogean G, Petrisor B, Adachi JDR, Bogoch E, Kleinlugtenbelt YV, Bhandari M.

Geriatr Orthop Surg Rehabil. 2017 Dec;8(4):215-224. doi: 10.1177/2151458517735201. Epub 2017 Oct 25.

9.

Improvements in osteoporosis testing and care are found following the wide scale implementation of the Ontario Fracture Clinic Screening Program: An interrupted time series analysis.

Beaton DE, Mamdani M, Zheng H, Jaglal S, Cadarette SM, Bogoch ER, Sale JEM, Sujic R, Jain R; Ontario Osteoporosis Strategy Fracture Clinic Screening Program Evaluation Team.

Medicine (Baltimore). 2017 Dec;96(48):e9012. doi: 10.1097/MD.0000000000009012.

10.

Ten-year follow-up study of three alternative bearing surfaces used in total hip arthroplasty in young patients: a prospective randomised controlled trial.

Atrey A, Ward SE, Khoshbin A, Hussain N, Bogoch E, Schemitsch EH, Waddell JP.

Bone Joint J. 2017 Dec;99-B(12):1590-1595. doi: 10.1302/0301-620X.99B12.BJJ-2017-0353.R1.

PMID:
29212681
11.

Vitamin D Use and Health Outcomes After Surgery for Hip Fracture.

Sprague S, Slobogean GP, Bogoch E, Petrisor B, Garibaldi A, O'Hara N, Bhandari M; FAITH Investigators.

Orthopedics. 2017 Oct 1;40(5):e868-e875. doi: 10.3928/01477447-20170907-01.

PMID:
29039872
12.

Equal treatment: no evidence of gender inequity in osteoporosis management in a coordinator-based fragility fracture screening program.

Ansari H, Beaton DE, Sujic R, Rotondi NK, Cullen JD, Slater M, Sale JEM, Jain R, Bogoch ER; Ontario Osteoporosis Strategy Fracture Screening and Prevention Program Evaluation Team.

Osteoporos Int. 2017 Dec;28(12):3401-3406. doi: 10.1007/s00198-017-4206-x. Epub 2017 Sep 10.

PMID:
28891035
14.

Fracture Prevention in the Orthopaedic Environment: Outcomes of a Coordinator-Based Fracture Liaison Service.

Bogoch ER, Elliot-Gibson V, Beaton D, Sale J, Josse RG.

J Bone Joint Surg Am. 2017 May 17;99(10):820-831. doi: 10.2106/JBJS.16.01042.

PMID:
28509822
15.

Addition of a fracture risk assessment to a coordinator's role improved treatment rates within 6 months of screening in a fragility fracture screening program.

Beaton DE, Vidmar M, Pitzul KB, Sujic R, Rotondi NK, Bogoch ER, Sale JEM, Jain R, Weldon J.

Osteoporos Int. 2017 Mar;28(3):863-869. doi: 10.1007/s00198-016-3794-1. Epub 2016 Oct 21.

PMID:
27770155
16.

The impact of fragility fractures on work and characteristics associated with time to return to work.

Rotondi NK, Beaton DE, Ilieff M, Adhihetty C, Linton D, Bogoch E, Sale J, Hogg-Johnson S, Jaglal S, Jain R, Weldon J.

Osteoporos Int. 2017 Jan;28(1):349-358. doi: 10.1007/s00198-016-3730-4. Epub 2016 Aug 5.

PMID:
27492487
17.

Comparison of CAROC and FRAX in Fragility Fracture Patients: Agreement, Clinical Utility, and Implications for Clinical Practice.

Rotondi NK, Beaton DE, Elliot-Gibson V, Sujic R, Josse RG, Sale JE, Leslie WD, Bogoch ER.

J Rheumatol. 2016 Aug;43(8):1593-9. doi: 10.3899/jrheum.151409. Epub 2016 Jun 15.

PMID:
27307534
18.

Men's health-seeking behaviours regarding bone health after a fragility fracture: a secondary analysis of qualitative data.

Sale JE, Ashe MC, Beaton D, Bogoch E, Frankel L.

Osteoporos Int. 2016 Oct;27(10):3113-9. doi: 10.1007/s00198-016-3641-4. Epub 2016 May 27.

PMID:
27234669
19.

Patient acceptance of osteoporosis treatment: Application of the stages of change model.

Sujic R, Beaton DE, Bogoch ER; Ontario Osteoporosis Strategy Fracture Clinic Screening Program Evaluation Team.

Maturitas. 2016 Jun;88:70-5. doi: 10.1016/j.maturitas.2016.03.021. Epub 2016 Mar 23.

PMID:
27105702
20.

Bone Mineral Density Reporting Underestimates Fracture Risk in Ontario.

Sale JE, Bogoch E, Meadows L, Gignac M, Frankel L, Inrig T, Beaton D, Jain R.

Health (Irvine Calif). 2015 May;7(5):566-571.

21.

What Do We Know about Individuals Who Are Assessed as Being at Moderate Risk for Future Fracture in Canada?

Sale JE, Jain R, Akilan K, Senior K, Beaton D, Bogoch E, Boire G, Beaulieu MC, Lightfoot D, Funnell L.

Health (Irvine Calif). 2015 May;7(5):514-520.

22.

Universal tranexamic acid therapy to minimize transfusion for major joint arthroplasty: a retrospective analysis of protocol implementation.

Baker JE, Pavenski K, Pirani RA, White A, Kataoka M, Waddell JP, Ho A, Schemitsch EH, Lo N, Bogoch ER, Pronovost A, Luke K, Howell A, Nassis A, Tsui AK, Tanzini RM, Pulendrarajah R, Mazer CD, Freedman J, Hare GM.

Can J Anaesth. 2015 Nov;62(11):1179-87. doi: 10.1007/s12630-015-0460-6. Epub 2015 Sep 3.

PMID:
26335903
23.

Patients do not have a consistent understanding of high risk for future fracture: a qualitative study of patients from a post-fracture secondary prevention program.

Sale JE, Gignac MA, Hawker G, Beaton D, Frankel L, Bogoch E, Elliot-Gibson V.

Osteoporos Int. 2016 Jan;27(1):65-73. doi: 10.1007/s00198-015-3214-y. Epub 2015 Jun 27.

PMID:
26115943
24.

Patient perceptions of provider barriers to post-fracture secondary prevention.

Sale JE, Bogoch E, Hawker G, Gignac M, Beaton D, Jaglal S, Frankel L.

Osteoporos Int. 2014 Nov;25(11):2581-9. doi: 10.1007/s00198-014-2804-4. Epub 2014 Aug 1.

PMID:
25082555
25.

Erratum to: Perceived messages about bone health after a fracture are not consistent across healthcare providers.

Sale JE, Hawker G, Cameron C, Bogoch E, Jain R, Beaton D, Jaglal S, Funnell L.

Rheumatol Int. 2015 Jan;35(1):105. doi: 10.1007/s00296-014-3090-3. No abstract available.

PMID:
25059574
26.

Perceived messages about bone health after a fracture are not consistent across healthcare providers.

Sale JE, Hawker G, Cameron C, Bogoch E, Jain R, Beaton D, Jaglal S, Funnell L.

Rheumatol Int. 2015 Jan;35(1):97-103. doi: 10.1007/s00296-014-3079-y. Epub 2014 Jun 25. Erratum in: Rheumatol Int. 2015 Jan;35(1):105.

PMID:
24962740
27.

A randomized controlled trial comparing Oxinium and cobalt-chrome on standard and cross-linked polyethylene.

Morison ZA, Patil S, Khan HA, Bogoch ER, Schemitsch EH, Waddell JP.

J Arthroplasty. 2014 Sep;29(9 Suppl):164-8. doi: 10.1016/j.arth.2014.04.046. Epub 2014 May 24.

PMID:
24961892
28.

Secondary prevention after an osteoporosis-related fracture: an overview.

Sale JE, Beaton D, Bogoch E.

Clin Geriatr Med. 2014 May;30(2):317-32. doi: 10.1016/j.cger.2014.01.009. Epub 2014 Mar 4. Review.

PMID:
24721371
29.

Increased surgeon experience with rheumatoid arthritis reduces the risk of complications following total joint arthroplasty.

Ravi B, Croxford R, Austin PC, Hollands S, Paterson JM, Bogoch E, Kreder H, Hawker GA.

Arthritis Rheumatol. 2014 Mar;66(3):488-96. doi: 10.1002/art.38205.

30.

Increased risk of complications following total joint arthroplasty in patients with rheumatoid arthritis.

Ravi B, Croxford R, Hollands S, Paterson JM, Bogoch E, Kreder H, Hawker GA.

Arthritis Rheumatol. 2014 Feb;66(2):254-63. doi: 10.1002/art.38231.

31.

Bone mineral density testing after fragility fracture: Informative test results likely.

Posen J, Beaton DE, Sale J, Bogoch ER.

Can Fam Physician. 2013 Dec;59(12):e564-71. Review.

32.

Strategies used by an osteoporosis patient group to navigate for bone health care after a fracture.

Sale JE, Cameron C, Hawker G, Jaglal S, Funnell L, Jain R, Bogoch E.

Arch Orthop Trauma Surg. 2014 Feb;134(2):229-35. doi: 10.1007/s00402-013-1889-0. Epub 2013 Nov 26.

PMID:
24276358
33.

Factors influencing the pharmacological management of osteoporosis after fragility fracture: results from the Ontario Osteoporosis Strategy's fracture clinic screening program.

Beaton DE, Dyer S, Jiang D, Sujic R, Slater M, Sale JE, Bogoch ER; Osteoporosis Fracture Clinic Screening Program Evaluation Team.

Osteoporos Int. 2014 Jan;25(1):289-96. doi: 10.1007/s00198-013-2430-6. Epub 2013 Jun 21.

PMID:
23794044
34.

Non-pharmacological strategies used by patients at high risk for future fracture to manage fracture risk--a qualitative study.

Sale JE, Gignac MA, Hawker G, Beaton D, Bogoch E, Webster F, Frankel L, Elliot-Gibson V.

Osteoporos Int. 2014 Jan;25(1):281-8. doi: 10.1007/s00198-013-2405-7. Epub 2013 Jun 6.

PMID:
23740423
35.

Partnership for fragility bone fracture care provision and prevention program (P4Bones): study protocol for a secondary fracture prevention pragmatic controlled trial.

Gaboury I, Corriveau H, Boire G, Cabana F, Beaulieu MC, Dagenais P, Gosselin S, Bogoch E, Rochette M, Filiatrault J, Laforest S, Jean S, Fansi A, Theriault D, Burnand B.

Implement Sci. 2013 Jan 24;8:10. doi: 10.1186/1748-5908-8-10.

36.

Medication initiation rates are not directly comparable across secondary fracture prevention programs: reporting standards based on a systematic review.

Sale JE, Beaton D, Posen J, Bogoch E.

J Clin Epidemiol. 2013 Apr;66(4):379-385.e4. doi: 10.1016/j.jclinepi.2012.10.013. Epub 2013 Jan 18. Review.

PMID:
23337783
37.

A systematic review and meta-analysis comparing complications following total joint arthroplasty for rheumatoid arthritis versus for osteoarthritis.

Ravi B, Escott B, Shah PS, Jenkinson R, Chahal J, Bogoch E, Kreder H, Hawker G.

Arthritis Rheum. 2012 Dec;64(12):3839-49. doi: 10.1002/art.37690. Review.

38.

Patient perceptions of the path to osteoporosis care following a fragility fracture.

Beaton DE, Sujic R, McIlroy Beaton K, Sale J, Elliot-Gibson V, Bogoch ER.

Qual Health Res. 2012 Dec;22(12):1647-58. doi: 10.1177/1049732312457467. Epub 2012 Aug 24.

PMID:
22923385
39.

Making the first fracture the last fracture: ASBMR task force report on secondary fracture prevention.

Eisman JA, Bogoch ER, Dell R, Harrington JT, McKinney RE Jr, McLellan A, Mitchell PJ, Silverman S, Singleton R, Siris E; ASBMR Task Force on Secondary Fracture Prevention.

J Bone Miner Res. 2012 Oct;27(10):2039-46. doi: 10.1002/jbmr.1698. Epub 2012 Jul 26.

40.

Juvenile arthritis patients report favorable subjective outcomes of hip arthroplasty despite poor standard outcome scores.

Jolles BM, Bogoch ER.

J Arthroplasty. 2012 Oct;27(9):1622-8. doi: 10.1016/j.arth.2012.02.024. Epub 2012 Apr 21.

PMID:
22522107
41.

A prospective randomised controlled trial comparing three alternative bearing surfaces in primary total hip replacement.

Nikolaou VS, Edwards MR, Bogoch E, Schemitsch EH, Waddell JP.

J Bone Joint Surg Br. 2012 Apr;94(4):459-65. doi: 10.1302/0301-620X.94B4.27735.

PMID:
22434459
42.

Secondary causes of osteoporosis in fracture patients.

Bogoch ER, Elliot-Gibson V, Wang RY, Josse RG.

J Orthop Trauma. 2012 Sep;26(9):e145-52. doi: 10.1097/BOT.0b013e3182323f2c.

PMID:
22377504
43.

Patients reject the concept of fragility fracture--a new understanding based on fracture patients' communication.

Sale JE, Gignac MA, Frankel L, Hawker G, Beaton D, Elliot-Gibson V, Bogoch E.

Osteoporos Int. 2012 Dec;23(12):2829-34. doi: 10.1007/s00198-012-1914-0. Epub 2012 Feb 7.

PMID:
22310958
44.

Key outcomes are usually not reported in published fracture secondary prevention programs: results of a systematic review.

Sale JE, Beaton D, Posen J, Elliot-Gibson V, Bogoch E.

Arch Orthop Trauma Surg. 2014 Feb;134(2):283-9. doi: 10.1007/s00402-011-1442-y. Epub 2011 Dec 11. Review.

PMID:
22160462
45.

Impact of a centralized osteoporosis coordinator on post-fracture osteoporosis management: a cluster randomized trial.

Jaglal SB, Donescu OS, Bansod V, Laprade J, Thorpe K, Hawker G, Majumdar SR, Meadows L, Cadarette SM, Papaioannou A, Kloseck M, Beaton D, Bogoch E, Zwarenstein M.

Osteoporos Int. 2012 Jan;23(1):87-95. doi: 10.1007/s00198-011-1726-7. Epub 2011 Jul 16.

46.

Systematic review on interventions to improve osteoporosis investigation and treatment in fragility fracture patients.

Sale JE, Beaton D, Posen J, Elliot-Gibson V, Bogoch E.

Osteoporos Int. 2011 Jul;22(7):2067-82. doi: 10.1007/s00198-011-1544-y. Epub 2011 May 24. Review.

PMID:
21607808
47.

Coordinator-based systems for secondary prevention in fragility fracture patients.

Marsh D, Akesson K, Beaton DE, Bogoch ER, Boonen S, Brandi ML, McLellan AR, Mitchell PJ, Sale JE, Wahl DA; IOF CSA Fracture Working Group.

Osteoporos Int. 2011 Jul;22(7):2051-65. doi: 10.1007/s00198-011-1642-x. Epub 2011 May 24. Review.

PMID:
21607807
48.

Decision to take osteoporosis medication in patients who have had a fracture and are 'high' risk for future fracture: a qualitative study.

Sale JE, Gignac MA, Hawker G, Frankel L, Beaton D, Bogoch E, Elliot-Gibson V.

BMC Musculoskelet Disord. 2011 May 9;12:92. doi: 10.1186/1471-2474-12-92.

49.

Hand appearance as a patient motivation for surgery and a determinant of satisfaction with metacarpophalangeal joint arthroplasty for rheumatoid arthritis.

Bogoch ER, Escott BG, Ronald K.

J Hand Surg Am. 2011 Jun;36(6):1007-1014.e1-4. doi: 10.1016/j.jhsa.2011.02.002. Epub 2011 May 6.

PMID:
21530103
50.

Biomechanical validation of finite element models for two silicone metacarpophalangeal joint implants.

Hussein AI, Stranart JC, Meguid SA, Bogoch ER.

J Biomech Eng. 2011 Feb;133(2):024501. doi: 10.1115/1.4003311.

PMID:
21280884

Supplemental Content

Loading ...
Support Center